Zura Bio Ltd (ZURA)
2.93
+0.03
(+1.03%)
USD |
NASDAQ |
Nov 21, 16:00
2.92
-0.01
(-0.34%)
After-Hours: 20:00
Zura Bio Enterprise Value: 20.87M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 20.87M |
| November 20, 2024 | 18.91M |
| November 19, 2024 | 35.23M |
| November 18, 2024 | 39.15M |
| November 15, 2024 | 35.89M |
| November 14, 2024 | 64.62M |
| November 13, 2024 | 115.55M |
| November 12, 2024 | 125.34M |
| November 11, 2024 | 137.75M |
| November 08, 2024 | 128.60M |
| November 07, 2024 | 121.42M |
| November 06, 2024 | 110.32M |
| November 05, 2024 | 97.92M |
| November 04, 2024 | 114.89M |
| November 01, 2024 | 115.55M |
| October 31, 2024 | 116.85M |
| October 30, 2024 | 131.87M |
| October 29, 2024 | 122.07M |
| October 28, 2024 | 130.56M |
| October 25, 2024 | 139.05M |
| October 24, 2024 | 129.91M |
| October 23, 2024 | 132.52M |
| October 22, 2024 | 150.80M |
| October 21, 2024 | 144.93M |
| October 18, 2024 | 150.80M |
| Date | Value |
|---|---|
| October 17, 2024 | 148.85M |
| October 16, 2024 | 125.34M |
| October 15, 2024 | 101.18M |
| October 14, 2024 | 94.65M |
| October 11, 2024 | 94.65M |
| October 10, 2024 | 81.59M |
| October 09, 2024 | 89.43M |
| October 08, 2024 | 104.45M |
| October 07, 2024 | 107.71M |
| October 04, 2024 | 115.55M |
| October 03, 2024 | 100.53M |
| October 02, 2024 | 88.78M |
| October 01, 2024 | 80.94M |
| September 30, 2024 | 94.65M |
| September 27, 2024 | 86.66M |
| September 26, 2024 | 80.28M |
| September 25, 2024 | 76.46M |
| September 24, 2024 | 82.19M |
| September 23, 2024 | 94.95M |
| September 20, 2024 | 110.26M |
| September 19, 2024 | 101.33M |
| September 18, 2024 | 90.49M |
| September 17, 2024 | 74.54M |
| September 16, 2024 | 56.05M |
| September 13, 2024 | 63.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.782M
Minimum
Mar 22 2024
895.35M
Maximum
Mar 23 2023
150.58M
Average
129.69M
Median
Apr 22 2024
Enterprise Value Benchmarks
| CEL-SCI Corp | 36.79M |
| AIM ImmunoTech Inc | 9.017M |
| IGC Pharma Inc | 25.89M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Protalix BioTherapeutics Inc | 94.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.70M |
| Total Expenses (Quarterly) | 19.32M |
| EPS Diluted (Quarterly) | -0.26 |
| Earnings Yield | -10.92% |